CYP2C19*2, CYP2C19*17 and ITGB3 (PlA1/A2) polymorphisms and resulting therapeutic alterations of clopidogrel and aspirin: A clinical screening among CVD patients who undergone PCI
Tasnova Tasnim Nova, Ishrat Jahan, NAM Momenuzzaman, Sikder Nahidul Islam Rabbi, Thomas M. C. Binder, Mohammad Safiqul Islam, Md. Rabiul Islam, Abul Hasnat, Zabun Nahar
The paper investigates genetic polymorphisms in CYP2C19 and ITGB3 genes and their impact on clopidogrel and aspirin efficacy in cardiovascular patients post-PCI.
bioRxiv · Oct 4, 2020 · PreprintGenetics